Remission in schizophrenia: one-year Ita
β
Alessandro Rossi; Anna BagalΓ ; Vincenzo Del Curatolo; Francesco Scapati; Micaela
π
Article
π
2009
π
John Wiley and Sons
π
English
β 155 KB
π 1 views
## Abstract ## Objectives To evaluate the maintenance of efficacy of risperidone longβacting injectable (RLAI) in stable patients with schizophrenia or schizoaffective disorders. The prevalence of patients who met standardized remission criteria will be also evaluated as well as the predictors fac